Inogen

157 articles with Inogen

• Inogen Names Agnes Lee as Senior Vice President of Investor Relations and Strategic Planning

  5/18/2022

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced the appointment of Agnes Lee to the position of Senior Vice President of Investor Relations and Strategic Planning, effective May 23, 2022.

• Inogen Announces First Quarter 2022 Financial Results

  5/5/2022

  Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three months ended March 31, 2022.

• Inogen to Announce First Quarter 2022 Financial Results on May 5, 2022

  4/14/2022

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2022 financial results after market close on Thursday, May 5, 2022.

• Inogen Announces Participation in the 21st Annual Needham Virtual Healthcare Conference

  3/30/2022

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that the Company’s management will be participating in the 21st Annual Needham Virtual Healthcare Conference.

• Inogen Announces Board of Director Changes

  3/23/2022

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced the appointment of Glenn Boehnlein, Kevin King, and Mary Katherine Ladone to Inogen’s Board of Directors, effective March 22, 2022.

• Inogen Names Kristin Caltrider as Chief Financial Officer

  3/4/2022

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced the appointment of Kristin Caltrider as EVP & Chief Financial Officer, effective March 21, 2022.

• Inogen Announces Fourth Quarter and Full Year 2021 Financial Results

  2/24/2022

  Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three- and twelve-month periods ended December 31, 2021.

• Inogen to Announce Fourth Quarter 2021 Financial Results on February 24, 2022

  1/26/2022

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release fourth quarter 2021 financial results after market close on Thursday, February 24, 2022.

• Inogen Announces Preliminary, Unaudited Full Year and Fourth Quarter 2021 Revenue Results

  1/10/2022

  Inogen, Inc. today reported preliminary, unaudited revenue results for the three-month and twelve-month periods ended December 31, 2021.

• Inogen Appoints Elizabeth Mora as Board Chairperson

  12/30/2021

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that Elizabeth Mora was elected as Board Chairperson.

• Inogen Revises Presentation Time at the 40th Annual J.P. Morgan Healthcare Conference

  12/16/2021

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that the Company’s presentation at the 40th Annual J.P. Morgan Healthcare Conference has been moved due to the conference moving into a virtual format.

• Inogen Announces CFO Transition Plan

  12/13/2021

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced the appointment of Mike Sergesketter as Interim Chief Financial Officer, effective immediately.

• Inogen Announces Third Quarter 2021 Financial Results

  11/4/2021

  Inogen, Inc. today reported financial results for the three months ended September 30, 2021.

• Inogen Announces Participation in the Stifel Virtual Healthcare Conference

  11/2/2021

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that the Company’s management will be participating in Stifel Virtual Healthcare Conference.

• Inogen to Announce Third Quarter 2021 Financial Results on November 4, 2021

  10/13/2021

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third quarter 2021 financial results after market close on Thursday, November 4, 2021.

• Inogen Appoints Stanislav Glezer as Chief Technology Officer

  10/12/2021

  Inogen, Inc. (NASDAQ: INGN), (“Inogen” or “the Company”), today announced that Stanislav Glezer, MD has been appointed to the role of Chief Technology Officer responsible for R&D and Engineering, Medical Affairs, and Regulatory Affairs.

• Inogen Strengthens Commercial Capabilities Through New Ashfield Relationship

  9/21/2021

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced an agreement to enhance its go-to-market capabilities with Ashfield Healthcare, LLC, part of UDG Healthcare.

• Inogen Announces Second Quarter 2021 Financial Results

  8/4/2021

  Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three months ended June 30, 2021.

• Inogen to Announce Second Quarter 2021 Financial Results on August 4, 2021

  7/14/2021

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2021 financial results after market close on Wednesday, August 4, 2021.

• Inogen Announces Appointment of General Counsel

  6/21/2021

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that its Board of Directors has appointed Jason Somer as Inogen’s Executive Vice President and General Counsel and Secretary, effective July 12, 2021.